ArticleThe Prostate2026
Intense Focal Peripheral Uptake Pattern on 18F-PET/PSMA as a Predictor of Histological Upgrading in Prostate Cancer.
Article in The Prostate, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIntraprostatic uptake patterns on 18F-PET/PSMA, such as those defined by the PRIMARY score, have been associated with clinically significant prostate cancer. However, the value of the peripheral focal intense uptake pattern (IFPUP), as a predictor of histologic upgrading after radical prostatectomy remains unclear.
objectiveTo determine whether the IFPUP is associated with histological upgrading in specimens obtained from radical prostatectomy in patients with prostate cancer.
methodsWe performed a retrospective cohort study including patients with localized prostate cancer who underwent PET/PSMA prior to radical prostatectomy between 2022 and 2024. Clinical, imaging, and pathology data were collected. IFPUP was defined as SUVmax ≥ 11.4. Histologic upgrading was defined as an increase in ISUP grade from biopsy to prostatectomy. Associations were evaluated using multivariable logistic regression; diagnostic performance was assessed by AUROC, sensitivity, specificity, and predictive values.
resultsThirty-four patients were included (median age 68 years, median PSA 12 ng/mL). Histologic upgrading occurred in 47.1% (16/34). IFPUP was observed in 33% and was significantly associated with upgrading (56% vs. 12%, p = 0.008). On multivariable analysis, IFPUP remained an independent predictor (OR 16.63, 95% CI 1.42-195.6, p = 0.025). Diagnostic performance of IFPUP included AUROC 0.722 (95% CI 0.574-0.870), sensitivity 56%, specificity 88%, positive predictive value 82%, and negative predictive value 68%.
conclusionsThe presence of IFPUP on PET/PSMA is an independent predictor of histologic upgrading in localized prostate cancer. Its high specificity and positive predictive value suggest clinical utility as a complementary preoperative biomarker for risk stratification, warranting validation in larger cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.